This site is intended for Healthcare professionals only.

Difference between landed Costs and MRP of Stents Too High: Admits HM

Difference between landed Costs and MRP of Stents Too High: Admits HM

New Delhi : Health Minister, Mr. J.P. Nadda  told parliament today that a  study conducted on the pricing of stents by the National Pharmaceutical Pricing Authority under the Department of Pharmaceuticals had observed that the difference between the landed cost and the MRP of stents imported  was  unreasonably high . He said that  bulk of medical devices including stents consumed in the country  were imported.

Mr. J.P. Nadda  while discussing the issue said this medical device fell under  the non-scheduled category of Drugs Price Control Order (DPCO), 2013 and as such, no ceiling price had been fixed for these devices. However, he said  DPCO, 2013 provides for monitoring the prices of these devices and also ensures that no manufacturer/importer/distributor is allowed to increase the MRP by more than ten percent  during the  preceding twelve months. The price of stents (Cardiac and Drug eluting stents)  have been notified as  ‘Drugs’ under the Drugs and cosmetic Act 1940.

Mr. Nadda further added that since Health was a state subject, data regarding annual requirements of stents in the country  was not complied centrally. He also highlighted that as per the direction of Hon’ble High Court of Delhi, a sub-committee has been constituted by the Ministry of Health and Family Welfare, seeking its views on the essential nature  of coronary stents and their inclusion in the National List of Essential Medicines.

 

Source: self
0 comment(s) on Difference between landed Costs and MRP of Stents Too High: Admits HM

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted